Lemaitre Vascular Inc. (LMAT) is an internationally recognized company in the development, manufacture, and distribution of medical devices used in the treatment of peripheral vascular disease. Founded in 1983 by surgeon George D. LeMaitre, the company's constant commitment to innovation and improvement has positioned it as a global leader in vascular surgery.
Lemaitre Vascular Inc. is publicly traded on the NASDAQ Global Market under the symbol LMAT. It is based in Burlington, Massachusetts, USA, with additional offices and distribution networks across North America, Europe, Asia, and Australia. This allows the company to service physicians, hospitals, and medical facilities throughout the world.
The company offers over 20 different types of medical devices, including the patented AlboGraft® Polyester Vascular Graft which is widely recognized for its superior resistance to aneurysm formation. Other innovative products range from embolectomy catheters, vascular grafts, valvulotomes, stent grafts, to carotid shunts and remote endarterectomy devices. The company also recently introduced the XenoSure® Biologic Patch to reduce bleeding in vascular surgery procedures.
Lemaitre Vascular Inc. is committed to the highest manufacturing and quality control standards, with manufacturing facilities in Massachusetts, California, Canada, and Italy that adhere strictly to the regulations of the U.S. Food & Drug Administration (FDA) and the European CE Mark.
Moreover, the company places a strong emphasis on maintaining close ties with the medical community. Through continuous dialogue with physicians and clinicians, Lemaitre Vascular Inc. can assess and respond swiftly to unmet clinical needs, driving the development and improvement of their products.
Despite its success, Lemaitre Vascular remains committed to the same passion and vision for innovation that it had as a small surgical start-up. This speaks volumes as to why Lemaitre Vascular Inc. is revered not only for its groundbreaking medical devices but also for its dedication in improving vascular care worldwide. With a continued emphasis on product refinement and development, the company is dedicated to fulfilling its mission of providing best-in-class vascular devices to surgeons and improving patient care.
In summary, Lemaitre Vascular Inc. exemplifies a successful medical device company that integrates continuous innovation, superior quality, and close interaction with the medical community, leading to improved treatment of peripheral vascular diseases and better outcomes for patients worldwide.